Pharmacological evaluation of drug therapies in Aicardi-Goutières syndrome: insights from patient-derived neural stem cells
Aicardi-Goutières syndrome (AGS) is a rare genetic disorder classified among type I interferonopathies. Current pharmacological management of AGS is symptomatic and supportive, with recent clinical applications of JAK inhibitors (JAKi) and antiretroviral therapies (RTIs). To investigate the effects...
Saved in:
| Main Authors: | Stefania Braidotti, Rosalba Monica Ferraro, Raffaella Franca, Elena Genova, Francesco Giambuzzi, Andrea Mancini, Valentina Marinozzi, Letizia Pugnetti, Giulia Zudeh, Alessandra Tesser, Alberto Tommasini, Giuliana Decorti, Silvia Clara Giliani, Gabriele Stocco |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1549183/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MRI Features Predictive of Aicardi-Goutieres Syndrome
by: J Gordon Millichap
Published: (2015-01-01) -
Interferon Biomarkers in Aicardi-Goutieres Syndrome
by: J Gordon Millichap, et al.
Published: (2014-01-01) -
A Case Report of Aicardi-Goutières Syndrome Type 7 Caused by IFIH1 Gene Mutation and a Literature Review
by: ZHAO Min, et al.
Published: (2024-10-01) -
A 33-year diagnostic odyssey in an Ashkenazi Jewish patient with Aicardi-Goutières syndrome
by: Oskar Schnappauf, PhD, et al.
Published: (2025-05-01) -
Talents Amidst Neurological Impairment; an Interesting Case of Aicardi–Goutières Syndrome
by: Pooneh Tabibi, et al.
Published: (2025-05-01)